| Phase 2 | 5 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT05099471 | Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia | Waldenstrom Macroglobulinemia | Recruiting | 2026-05-05 |
| NCT04263480 | Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in… | Waldenstrom Macroglobulinemia | Active, Not Recruiting | 2026-05-12 |
| NCT03322865 | Obinutuzumab in Marginal Zone Lymphoma | Marginal Zone Lymphoma | Active, Not Recruiting | 2026-05-06 |
| NCT03474744 | Copanlisib and Rituximab in Marginal Zone Lymphoma Patients | Marginal Zone Lymphoma | Active, Not Recruiting | 2026-05-06 |
| NCT03620903 | Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia | Waldenstrom Macroglobulinemia | Active, Not Recruiting | 2025-12-05 |